Related Experiment Video
Updated: Oct 11, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Molecular Modeling Techniques Applied to the Design of Multitarget Drugs: Methods and Applications
Larissa Henriques Evangelista Castro1, Carlos Mauricio R Sant'Anna1,2
1Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, Brasil.
Abstract:
Multifactorial diseases, such as cancer and diabetes present a challenge for the traditional "one-target, one disease" paradigm due to their complex pathogenic mechanisms. Although a combination of drugs can be used, a multitarget drug may be a better choice due to its efficacy, lower adverse effects and lower chance of resistance development. The computer-based design of these multitarget drugs can explore the same techniques used for single-target drug design, but the difficulties associated with the obtention of drugs that are capable of modulating two or more targets with similar efficacy impose new challenges, whose solutions involve the adaptation of known techniques and also to the development of new ones, including machine-learning approaches. In this review, some SBDD and LBDD techniques for the multitarget drug design are discussed, together with some cases where the application of such techniques led to effective multitarget ligands.
Insights
Designing multitarget drugs offers advantages over traditional single-target approaches for complex diseases like cancer and diabetes. Computer-aided design, including machine learning, is advancing the development of effective multitarget ligands.
Area of Science:
- Pharmacology and Computational Chemistry
- Drug Discovery and Development
Background:
- Multifactorial diseases like cancer and diabetes challenge the traditional "one-target, one-disease" drug design model.
- Multitarget drugs offer potential advantages over drug combinations, including improved efficacy, reduced adverse effects, and lower resistance development.
Purpose of the Study:
- To review Structure-Based Drug Design (SBDD) and Ligand-Based Drug Design (LBDD) techniques for multitarget drug discovery.
- To highlight the challenges and advancements in designing drugs that modulate multiple targets effectively.
Main Methods:
- Discussion of established SBDD and LBDD methodologies adapted for multitarget drug design.
- Exploration of novel approaches, including machine-learning techniques, to address design complexities.
- Review of case studies demonstrating successful multitarget ligand development.
Main Results:
- Computer-aided design techniques are applicable to multitarget drug discovery.
- Adaptation and development of novel computational methods are crucial for overcoming design challenges.
- Successful identification of effective multitarget ligands has been achieved using these techniques.
Conclusions:
- Multitarget drug design is a promising strategy for complex diseases.
- Computational approaches, particularly machine learning, are vital for advancing multitarget drug discovery.
- Further development of SBDD and LBDD techniques will enhance the creation of effective multitarget therapeutics.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...